119 related articles for article (PubMed ID: 21946193)
1. Sickness behavior clustering in children with cancer.
Hockenberry MJ; Hooke MC; McCarthy K; Gregurich MA
J Pediatr Oncol Nurs; 2011; 28(5):263-72. PubMed ID: 21946193
[TBL] [Abstract][Full Text] [Related]
2. Symptom clusters in children and adolescents receiving cisplatin, doxorubicin, or ifosfamide.
Hockenberry MJ; Hooke MC; Gregurich M; McCarthy K; Sambuco G; Krull K
Oncol Nurs Forum; 2010 Jan; 37(1):E16-27. PubMed ID: 20044328
[TBL] [Abstract][Full Text] [Related]
3. Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin, ifosfamide, or doxorubicin.
Hockenberry MJ; Hooke MC; Gregurich M; McCarthy K
J Pediatr Hematol Oncol; 2009 Sep; 31(9):664-9. PubMed ID: 19707160
[TBL] [Abstract][Full Text] [Related]
4. Cancer symptom clusters: clinical and research methodology.
Kirkova J; Aktas A; Walsh D; Davis MP
J Palliat Med; 2011 Oct; 14(10):1149-66. PubMed ID: 21861613
[TBL] [Abstract][Full Text] [Related]
5. Cancer symptom clusters: old concept but new data.
Kirkova J; Walsh D; Aktas A; Davis MP
Am J Hosp Palliat Care; 2010 Jun; 27(4):282-8. PubMed ID: 20351131
[TBL] [Abstract][Full Text] [Related]
6. Symptom clusters in children.
Rodgers CC; Hooke MC; Hockenberry MJ
Curr Opin Support Palliat Care; 2013 Mar; 7(1):67-72. PubMed ID: 23108342
[TBL] [Abstract][Full Text] [Related]
7. I look funny and I feel bad. Measurement of symptom distress.
Schneider SM
J Child Fam Nurs; 1999; 2(5):380-4. PubMed ID: 10795194
[No Abstract] [Full Text] [Related]
8. Fatigue and carnitine levels over multiple cycles of chemotherapy in children and adolescents.
Hooke MC; McCarthy K; Taylor O; Hockenberry MJ
Eur J Oncol Nurs; 2015 Feb; 19(1):7-12. PubMed ID: 25260954
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of the effect of a home-based multimodal symptom-management program in children and adolescents undergoing chemotherapy.
Cheng KK; Tan LML
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1336. PubMed ID: 33586920
[TBL] [Abstract][Full Text] [Related]
10. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community.
Hickok JT; Roscoe JA; Morrow GR; King DK; Atkins JN; Fitch TR
Cancer; 2003 Jun; 97(11):2880-6. PubMed ID: 12767103
[TBL] [Abstract][Full Text] [Related]
11. Symptom cluster patterns during the first year after diagnosis with cancer.
Molassiotis A; Wengström Y; Kearney N
J Pain Symptom Manage; 2010 May; 39(5):847-58. PubMed ID: 20226621
[TBL] [Abstract][Full Text] [Related]
12. WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms.
Kearney N; Miller M; Maguire R; Dolan S; MacDonald R; McLeod J; Maher L; Sinclair L; Norrie J; Wengström Y
Eur J Oncol Nurs; 2008 Dec; 12(5):443-8. PubMed ID: 18842457
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced neuropathic pain and its relation to cluster symptoms in breast cancer patients treated with paclitaxel.
Golan-Vered Y; Pud D
Pain Pract; 2013 Jan; 13(1):46-52. PubMed ID: 22533683
[TBL] [Abstract][Full Text] [Related]
14. Behavioral distress in pediatric patients with cancer receiving chemotherapy.
Dolgin MJ; Katz ER; Zeltzer LK; Landsverk J
Pediatrics; 1989 Jul; 84(1):103-10. PubMed ID: 2740159
[TBL] [Abstract][Full Text] [Related]
15. Consistency of symptom clusters in advanced cancer.
Kirkova J; Aktas A; Walsh D; Rybicki L; Davis MP
Am J Hosp Palliat Care; 2010 Aug; 27(5):342-6. PubMed ID: 20466939
[TBL] [Abstract][Full Text] [Related]
16. Changes in children's reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy.
Baggott C; Dodd M; Kennedy C; Marina N; Matthay KK; Cooper BA; Miaskowski C
J Pediatr Oncol Nurs; 2010; 27(6):307-15. PubMed ID: 20739586
[TBL] [Abstract][Full Text] [Related]
17. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.
Payne JK; Held J; Thorpe J; Shaw H
Oncol Nurs Forum; 2008 Jul; 35(4):635-42. PubMed ID: 18591167
[TBL] [Abstract][Full Text] [Related]
18. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P
Anticancer Res; 2000; 20(6C):4777-83. PubMed ID: 11205218
[TBL] [Abstract][Full Text] [Related]
19. Symptom cluster research: conceptual, design, measurement, and analysis issues.
Barsevick AM; Whitmer K; Nail LM; Beck SL; Dudley WN
J Pain Symptom Manage; 2006 Jan; 31(1):85-95. PubMed ID: 16442485
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
